MOLECULAR BIOSYSTEMS INC
10-Q, EX-27, 2000-08-14
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: MOLECULAR BIOSYSTEMS INC, 10-Q, EX-10.1, 2000-08-14
Next: SIERRA PACIFIC DEVELOPMENT FUND II, 10-Q, 2000-08-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED FINANCIAL STATEMENTS OF MOLECULAR BIOSYSTEMS, INC. DATED JUNE 30,
2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          MAR-31-2001
<PERIOD-START>                             APR-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                           3,069
<SECURITIES>                                     7,436
<RECEIVABLES>                                      357
<ALLOWANCES>                                         0
<INVENTORY>                                        213
<CURRENT-ASSETS>                                11,157
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                  12,955
<CURRENT-LIABILITIES>                            4,290
<BONDS>                                              0
                                0
                                          0
<COMMON>                                           186
<OTHER-SE>                                       8,479
<TOTAL-LIABILITY-AND-EQUITY>                    12,955
<SALES>                                              0
<TOTAL-REVENUES>                                 3,133
<CGS>                                                0
<TOTAL-COSTS>                                    1,224
<OTHER-EXPENSES>                                 2,220
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  98
<INCOME-PRETAX>                                  (282)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                              (282)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (282)
<EPS-BASIC>                                      (.01)
<EPS-DILUTED>                                    (.01)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission